REG-Convatec Group PLC Convatec Group PLC:

ConvaTecAnnouncement

31/10/2022 12:15

============

   Convatec Group PLC (CTEC)
   Convatec Group PLC:

   31-Oct-2022 / 12:00 GMT/BST
   Dissemination of a Regulatory Announcement, transmitted by EQS Group.
   The issuer is solely responsible for the content of this announcement.

   ══════════════════════════════════════════════════════════════════════════

   31 October 2022

                               Convatec Group Plc
                         ("Convatec" or "the Company")

                              Total Voting Rights

   The following notification  is made  in accordance with  the UK  Financial
   Conduct Authority's  Disclosure  and Transparency  Rule  5.6.1. As  at  31
   October 2022, the Company's issued capital with voting rights consisted of
   2,043,872,048 ordinary shares of 10p each (‘Shares’). The Company does not
   hold any Shares in Treasury at the date of this disclosure.

   The above  figure  (2,043,872,048) can  be  used by  shareholders  as  the
   denominator for  the  calculations  by  which to  determine  if  they  are
   required to notify their  interest in, or a  change to, their interest  in
   the Company  under the  UK Financial  Conduct Authority's  Disclosure  and
   Transparency Rules. 

    

   Enquiries 

   Analysts and Investors 

   Kate Postans, VP Investor Relations,
   Convatec                                                            +44
   (0)782 644 7807 

    1 ir@convatec.com 

    

   Media 

   Buchanan: Charles Ryland / Chris Lane              
                                                               +44 (0)207 466
   5000                                            

   Convatec Group Plc’s LEI code is 213800LS272L4FIDOH92 

    

   About Convatec 
    

   Pioneering trusted medical solutions to improve the lives we touch:
   Convatec is a global medical products and technologies company, focused on
   solutions for the management of chronic conditions, with leading positions
   in advanced wound care, ostomy care, continence and critical care, and
   infusion care. With around 10,000 colleagues, and a promise to be forever
   caring, our products and services are available in over 100 countries. Our
   solutions provide a range of benefits, from infection prevention and
   protection of at-risk skin, to improved patient outcomes and reduced care
   costs. The company is a constituent of the FTSE 100 Index (LSE:CTEC) and
   in 2021 revenues were over $2 billion. To learn more about Convatec,
   please visit  2 http://www.convatecgroup.com

   ══════════════════════════════════════════════════════════════════════════

   ISIN:          GB00BD3VFW73
   Category Code: TVR
   TIDM:          CTEC
   LEI Code:      213800LS272L4FIDOH92
   Sequence No.:  196178
   EQS News ID:   1469733


    
   End of Announcement EQS News Service

   ══════════════════════════════════════════════════════════════════════════

    3 fncls.ssp?fn=show_t_gif&application_id=1469733&application_name=news&site_id=refinitiv

References

   Visible links
   1. mailto:ir@convatec.com
   2. https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=redirect&url=26f8de477e9a42123589f91471356e0b&application_id=1469733&site_id=refinitiv&application_name=news


============